TABLE 2.
Overall Cohort at Baseline (N = 51) | OSD-Related Pain at Follow-up (n = 17) | No OSD-Related Pain at Follow-up (n = 29) | |
---|---|---|---|
Female sex | 22 (48) | 9 (53) | 13 (45) |
Age, y | 12.7 ± 1.1 | 12.7 ± 0.7 | 12.7 ± 1.3 |
Height, cm | 165.5 ± 8.4 | 167.5 ± 7.2 | 163.7 ± 9.0 |
Weight, kg | 56 ± 10 | 56 ± 9 | 54 ± 10 |
Symptoms | |||
Pain duration, mo | 21 ± 12 | 20 ± 10 | 21 ± 14 |
Bilateral pain | 35 (66)b | 6 (38) | 8 (28) |
Time from PHV | |||
Pre-PHV | 8 (16) | 2 (12) | 4 (14) |
Around-PHV | 29 (57) | 10 (59) | 17 (59) |
Post-PHV | 14 (27) | 5 (29) | 8 (28) |
aData are presented as mean ± SD or n (%). OSD, Osgood-Schlatter disease; PHV, peak height velocity.
bMissing data from 1 participant.